Find a Commonwealth Resource
Abiraterone acetate
HealthData.Gov
Updated Jul 6, 2026
About this dataset
Abiraterone Acetate is a prescription oral tablet with 250 mg of the active ingredient, used to treat metastatic castration-resistant prostate cancer in men. It's a generic version manufactured by Rising Pharma Holdings, Inc., approved under ANDA208371. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Abiraterone acetate
Access the FDA dataset for Abiraterone acetate — ANDA 203308 submitted by Mylan Institutional LLC
Modified Mar 24, 2026